Skip to content 
The DECODE-PD goes beyond great research towards PD treatment, and hopefully, a cure. We also focus our attention to prevention.
Strong evidence has shown that prevention plays a big role on the development of Parkinson’s disease. Being able to treat and control a disease is always a big step forward, but halting or preventing it from happening is even better!
For the studies below, our aim is to recruit those individuals that do not have a Parkinson’s disease diagnosis.
NADage
The NADage study aims to investigate the potential of nicotinamide riboside (NR) in reducing physical and cognitive decline in the frail population, while improving clinical symptoms of frailty.
NOR-RBD
NOR-RBD is the world’s first preventive trials in Parkinson’s disease and will recruit individuals in the prodromal phase, identified via REM sleep behavior disorder (RBD).
NADream
NADream aims to investigate the effects of NR on sleep quality in healthy adults. The hypothesis is that NR may improve the brain’s ability to “rest” during sleep, which may result in better sleep quality.
